OptimizeRx Sets Third Quarter 2020 Conference Call for Monday, November 9, 2020 at 4:30 p.m. ET
26 Ottobre 2020 - 12:31PM
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital
health solutions for life science companies, physicians and
patients, will hold a conference call on Monday, November 9, 2020
at 4:30 p.m. Eastern time to discuss its results for the third
quarter ended September 30, 2020. OptimizeRx management will host
the call, followed by a question and answer period.
As earlier reported, the company expects to report record
revenue for the quarter of more than $10.0 million, up over 100%
from the same year-ago quarter, along with positive non-GAAP net
income.
On the call, management will review how this growth has been
driven organically by a combination of enterprise deals and
tactical programs, as the company’s life science customers
increasingly see the value in transparent access to physicians and
patients provided by the OptimizeRx Digital Health Platform.
The full financial results for the quarter will be issued in a
press release prior to the call.
Conference Call
InformationDate: Monday, November 9, 2020Time: 4:30 p.m.
Eastern time (1:30 p.m. Pacific time)Toll-free dial-in number:
1-800-430-8332International dial-in number:
1-323-347-3277Conference ID: 9818386
Please call the conference telephone number five minutes prior
to the start time. An operator will register your name and
organization. If you have any difficulty connecting with the
conference call, please contact CMA at 1-949-432-7566.
A replay of the call will be available after 7:30 p.m. Eastern
time on the same day through November 30, 2020, as well as
available for replay via the Investors section of the OptimizeRx
website at www.optimizerx.com/investors.
Toll-free replay number: 1-844-512-2921International replay
number: 1-412-317-6671Replay ID: 9818386
About OptimizeRxOptimizeRx is a
digital health company that provides communications solutions for
life science companies, physicians and patients. Connecting over
half of healthcare providers in the U.S. and millions of
patients through a proprietary network,
the OptimizeRx digital health platform helps patients
afford and stay on medications. The platform unlocks new patient
and physician touchpoints for life science companies along the
patient journey, from point-of-care, to retail pharmacy, through
mobile patient engagement.
For more information, follow the company on
Twitter, LinkedIn or visit www.optimizerx.com.
Important Cautions Regarding Forward Looking
Statements This
press release contains forward-looking statements within the
definition of Section 27A of the Securities Act of 1933, as
amended, and such as in section 21E of the Securities Act of 1934,
as amended. These forward-looking statements should not be used to
make an investment decision. The words 'estimate,' 'possible' and
'seeking' and similar expressions identify forward-looking
statements, which speak only as to the date the statement was made.
The company undertakes no obligation to publicly update or revise
any forward-looking statements, whether because of new information,
future events, or otherwise. Forward-looking statements are
inherently subject to risks and uncertainties, some of which cannot
be predicted, or quantified. Future events and actual results could
differ materially from those set forth in, contemplated by, or
underlying the forward-looking statements. The risks and
uncertainties to which forward-looking statements are subject
include, but are not limited to, the effect of government
regulation, competition and other material risks.
OptimizeRx Contact Doug Baker, CFOTel
(248) 651-6568
(x807)dbaker@optimizerx.com
Media Contact Maira Alejandra, Media Relations
ManagerTel (754) 245-7070 malejandra@optimizerx.com
Investor Relations Contact Ron Both,
CMA Tel (949) 432-7557 oprx@cma.team
Grafico Azioni OptimizeRx (NASDAQ:OPRX)
Storico
Da Set 2024 a Ott 2024
Grafico Azioni OptimizeRx (NASDAQ:OPRX)
Storico
Da Ott 2023 a Ott 2024